MARY NUSSBAUM: Open Payments
NPI 1396479440 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 34 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $361 · 2025 $757
Food & beverage: $649Education: $108
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $248 |
| ABBVIE INC. | 11 | $158 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| GENZYME CORPORATION | 2 | $58 |
| Incyte Corporation | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| PFIZER INC. | 2 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $19 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Sotyktu, OPZELURA, ILUMYA, Rhapsido, COSENTYX.
Industry payments across MI — which companies pay providers there.
